title: Analysis of ascites from patients with ovarian carcinoma by cell flow cytometry.
abstract: Cell flow cytometry offers the opportunity to analyze cytopathological samples with regards to DNA content and proliferative activity. To investigate whether this modality can quantitate certain aspects of ovarian carcinoma by analyzing ascites, 43 samples from patients with advanced papillary serous adenocarcinoma of the ovary were studied. In 28 samples (65%) ploidy and the percentage of cells in S phase (%S phase) could be analyzed. Fifteen samples could not be analyzed because of overlapping cell populations distorting distinct cell cycle phases. Of the 28 samples studied, 8 (29%) were diploid and 20 (71%) were aneuploid. The DNA in aneuploid samples ranged from 1.23 to 2.65. The %S phase for aneuploid was greater than that for diploid samples. Patients with diploid samples survived longer. Cytometric analysis of cells from ascites in 4 patients in whom disease progressed after they received chemotherapy showed that the percentage of cells in S phase increased. Cells from ascites established in vitro showed that ploidy and proliferative activity changed as cells were passed in culture. In conclusion, the analysis of ascites by cell flow cytometry may be a prognosticator in patients with advanced ovarian carcinoma. In addition, conclusions extrapolated from in vitro data to the in vivo situation should be done cautiously since late-passaged cells may not always be representative of the initial tumor sample.
authors.affiliation: Department of Obstetrics and Gynecology, University of Chicago Pritzker School of Medicine, Illinois 60637.
authors.forename: J
authors.initials: J
authors.lastname: Rotmensch
authors.forename: R W
authors.initials: RW
authors.lastname: Atcher
authors.forename: J L
authors.initials: JL
authors.lastname: Schwartz
authors.forename: D J
authors.initials: DJ
authors.lastname: Grdina
mesh_terms: D000782:Aneuploidy; D001201:Ascites / Q000473:pathology*; D002455:Cell Division; D046508:Culture Techniques / Q000379:methods; D003536:Cystadenocarcinoma / Q000473:pathology* / Q000601:surgery; D004273:DNA, Neoplasm / Q000032:analysis*; D004171:Diploidy; D005260:Female; D005434:Flow Cytometry / Q000379:methods; D005500:Follow-Up Studies; D006801:Humans; D007700:Kinetics; D009367:Neoplasm Staging; D010051:Ovarian Neoplasms / Q000473:pathology* / Q000601:surgery; D011379:Prognosis; D016196:S Phase; D014407:Tumor Cells, Cultured
chemical_list: D004273:DNA, Neoplasm